Long-term Safety and Efficacy of the Derivo Embolization Device in a Single-center Series.

Acandis Aneurysm Endovascular Low-profile stent Outcome

Journal

Clinical neuroradiology
ISSN: 1869-1447
Titre abrégé: Clin Neuroradiol
Pays: Germany
ID NLM: 101526693

Informations de publication

Date de publication:
30 May 2024
Historique:
received: 03 01 2024
accepted: 05 05 2024
medline: 30 5 2024
pubmed: 30 5 2024
entrez: 30 5 2024
Statut: aheadofprint

Résumé

This study analyzes the long-term clinical and angiographic outcomes of the Derivo Embolization Device (DED), an advanced flow diverter device with an electropolished surface, for the treatment of intracranial aneurysms. A consecutive series of 101 patients (mean age: 58 years, 72% female) treated with the DED for 122 aneurysms at a single center between 2017 and 2023 was retrospectively analyzed for major (change in National Institutes of Health Stroke Scale [NIHSS] score ≥ 4 points) and minor (change in NIHSS score < 4 points) neurological events, procedural morbidity (increase of at least one point on the modified Rankin Scale), and angiographic results. There were 14 (11%) recurrent aneurysms, 15 (12%) ruptured aneurysms, 26 (21%) posterior circulation aneurysms and 16 (13%) fusiform or dissecting aneurysms. Device deployment failed in 1 case (1%). Procedure-related symptomatic procedural complications consisted of 2 (2%) major events (1 major stroke and 1 vessel perforation with intracranial hemorrhage and infarction) and 6 minor events (6 minor strokes). Procedural morbidity was 5%. There were no late ischemic or hemorrhagic events during follow-up. Complete and favorable aneurysm occlusion was achieved in 54% (40/74) and 62% (46/74) at a mean of 5 months, 71% (27/38) and 87% (33/38) at a mean of 12 months, and 76% (25/33) and 97% (32/33) at a mean of 35 months, respectively. The results demonstrate progressive aneurysm occlusion beyond 12 months after DED implantation with an almost 100% favorable occlusion rate. Procedural morbidity was low and there were no late complications.

Identifiants

pubmed: 38814452
doi: 10.1007/s00062-024-01423-1
pii: 10.1007/s00062-024-01423-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s).

Références

Shankar JJS, Tampieri D, Iancu D, et al. SILK flow diverter for complex intracranial aneurysms: a Canadian registry. J NeuroIntervent Surg. 2015; 2015–11708.
Chalouhi N, Tjoumakaris S, Starke RM, et al. Comparison of flow diversion and coiling in large unruptured intracranial saccular aneurysms. Stroke. 2013;44:2150–4.
doi: 10.1161/STROKEAHA.113.001785 pubmed: 23723311
Awad AJ, Mascitelli JR, Haroun RR, et al. Endovascular management of fusiform aneurysms in the posterior circulation: the era of flow diversion. Neurosurg Focus. 2017;42:E14.
doi: 10.3171/2017.3.FOCUS1748 pubmed: 28565985
Wakhloo AK, Gounis MJ. Revolution in aneurysm treatment: flow diversion to cure aneurysms: a paradigm shift. Neurosurgery. 2014;61:111–20.
doi: 10.1227/NEU.0000000000000392 pubmed: 25032539
Kallmes DF, Hanel R, Lopes D, et al. International retrospective study of the pipeline embolization device: a multicenter aneurysm treatment study. AJNR Am J Neuroradiol. 2015;36:108–15.
doi: 10.3174/ajnr.A4111 pubmed: 25355814 pmcid: 7965920
Brinjikji W, Murad MH, Lanzino G, et al. Endovascular treatment of intracranial aneurysms with flow diverters: a meta-analysis. Stroke. 2013;44:442–7.
doi: 10.1161/STROKEAHA.112.678151 pubmed: 23321438
Chiu A, Cheung A, Wenderoth J, et al. Long-term follow-up results following elective treatment of unruptured intracranial aneurysms with the pipeline embolization device. AJNR Am J Neuroradiol. 2015;36:1728–34.
doi: 10.3174/ajnr.A4329 pubmed: 25999412 pmcid: 7968755
Brinjikji W, Lanzino G, Cloft HJ, et al. Risk factors for Ischemic complications following pipeline embolization device treatment of Intracranial aneurysms: results from the IntrePED study. AJNR Am J Neuroradiol. 2016;37:1673–8.
doi: 10.3174/ajnr.A4807 pubmed: 27102308 pmcid: 7984677
Guédon A, Clarençon F, Di Maria F, et al. Very late ischemic complications in flow-diverter stents: a retrospective analysis of a single-center series. JNS. 2016;125:929–35.
doi: 10.3171/2015.10.JNS15703
Rossen JD, Chalouhi N, Wassef SN, et al. Incidence of cerebral ischemic events after discontinuation of clopidogrel in patients with intracranial aneurysms treated with stent-assisted techniques. JNS. 2012;117:929–33.
doi: 10.3171/2012.8.JNS12185
Kallmes DF, Brinjikji W, Cekirge S, et al. Safety and efficacy of the Pipeline embolization device for treatment of intracranial aneurysms: a pooled analysis of 3 large studies. J Neurosurg. 2017;127:775–80.
doi: 10.3171/2016.8.JNS16467 pubmed: 27791519
Kallmes DF, Brinjikji W, Boccardi E, et al. Aneurysm study of pipeline in an observational registry (ASPIRe). Intervent Neurol. 2016;5:89–99.
doi: 10.1159/000446503
Saatci I, Yavuz K, Ozer C, et al. Treatment of intracranial aneurysms using the pipeline flow-diverter embolization device: a single-center experience with long-term follow-up results. AJNR Am J Neuroradiol. 2012;33:1436–46.
doi: 10.3174/ajnr.A3246 pubmed: 22821921 pmcid: 7966552
Taschner CA, Stracke CP, Dorn F, et al. Derivo embolization device in the treatment of unruptured intracranial aneurysms: a prospective multicenter study. J NeuroIntervent Surg. 2021;13:541–6.
doi: 10.1136/neurintsurg-2020-016303
Goertz L, Dorn F, Kraus B, et al. Improved occlusion rate of Intracranial aneurysms treated with the Derivo embolization device: one-year clinical and angiographic follow-up in a multicenter study. World Neurosurg. 2019; https://doi.org/10.1016/j.wneu.2019.03.137 .
doi: 10.1016/j.wneu.2019.03.137 pubmed: 31901493
Trivelato FP, Abud DG, Ulhôa AC, et al. Derivo embolization device for the treatment of intracranial aneurysms: a multicenter study of 183 aneurysms. Stroke. 2019;50:2351–8.
doi: 10.1161/STROKEAHA.119.025407 pubmed: 31288675
O‘kelly C, Krings T, Fiorella D, et al. A novel grading scale for the angiographic assessment of intracranial aneurysms treated using flow diverting stents. Interv Neuroradiol. 2010;16:133–7.
doi: 10.1177/159101991001600204 pubmed: 20642887 pmcid: 3277972
Essbaiheen F, AlQahtani H, Almansoori TM, et al. Transient in-stent stenosis at mid-term angiographic follow-up in patients treated with SILK flow diverter stents: incidence, clinical significance and long-term follow-up. J NeuroIntervent Surg. 2019;11:166–70.
doi: 10.1136/neurintsurg-2018-013928
Piñana C, Remollo S, Zamarro J, et al. Derivo embolization device for intracranial aneurysms: a Spanish multicenter retrospective study. J NeuroIntervent Surg. 2023;15:871–5.
doi: 10.1136/jnis-2022-019220
Piano M, Lozupone E, Sgoifo A, et al. Long-term follow-up of the Derivo® Embolization Device (DED®) for intracranial aneurysms: the Italian Multicentric Registry. J Neurosurg Sci. 2021;65:361–8.
doi: 10.23736/S0390-5616.21.05300-5 pubmed: 33879762
Chalouhi N, Zanaty M, Whiting A, et al. Safety and efficacy of the pipeline embolization device in 100 small intracranial aneurysms. JNS. 2015;122:1498–502.
doi: 10.3171/2014.12.JNS14411
Trivelato FP, Rezende MTS, Ulhôa AC, et al. Occlusion rates of intracranial aneurysms treated with the Pipeline embolization device: the role of branches arising from the sac. JNS. 2018;130:543–9.
Lylyk I, Scrivano E, Lundquist J, et al. Pipeline embolization devices for the treatment of intracranial aneurysms, single-center registry: long-term angiographic and clinical outcomes from 1000 aneurysms. Neurosurgery. 2021;89:443.
doi: 10.1093/neuros/nyab183 pubmed: 34098575 pmcid: 8374967
Becske T, Brinjikji W, Potts MB, et al. Long-term clinical and angiographic outcomes following pipeline embolization device treatment of complex internal carotid artery aneurysms: five-year results of the pipeline for uncoilable or failed aneurysms trial. Neurosurgery. 2017;80:40–8.
doi: 10.1093/neuros/nyw014 pubmed: 28362885
Cagnazzo F, Di Carlo D, Cappucci M, et al. Acutely ruptured intracranial aneurysms treated with flow-diverter stents: a systematic review and meta. Analysis Am J Neuroradiol. 2018;39:1669–75.
doi: 10.3174/ajnr.A5730 pubmed: 30049721
Wang C, Luo B, Li T, et al. Comparison of the Pipeline embolisation device alone or combined with coiling for treatment of different sizes of intracranial aneurysms. Stroke Vasc Neurol. 2022;7:352. https://doi.org/10.1136/svn-2021-001258 .
doi: 10.1136/svn-2021-001258
Chalouhi N, Tjoumakaris S, Phillips J, et al. A single pipeline embolization device is sufficient for treatment of intracranial aneurysms. AJNR Am J Neuroradiol. 2014;35:1562–6.
doi: 10.3174/ajnr.A3957 pubmed: 24788125 pmcid: 7964452
Cagnazzo F, Ahmed R, Dargazanli C, et al. Treatment of wide-neck intracranial aneurysms with the Woven EndoBridge device associated with stenting: a single-center experience. AJNR Am J Neuroradiol. 2019;40:820–6.
doi: 10.3174/ajnr.A6032 pubmed: 30975649 pmcid: 7053896
You W, Lv J, Li Z, et al. The incidence and predictors of in-stent stenosis after pipeline flow-diverter stenting for intracranial aneurysm treatment. Front Neurol. 2023;14:1140497.
doi: 10.3389/fneur.2023.1140497 pubmed: 37181557 pmcid: 10166875
Mühl-Benninghaus R, Haußmann A, Simgen A, et al. Transient in-stent stenosis: a common finding after flow diverter implantation. J NeuroIntervent Surg. 2019;11:196–9.
doi: 10.1136/neurintsurg-2018-013975
Lauzier DC, Cler SJ, Osbun JW, et al. Management of in-stent stenosis with dual antiplatelet therapy following pipeline embolization of intracranial aneurysms. World Neurosurg. 2022;167:e303–e9.
doi: 10.1016/j.wneu.2022.08.002 pubmed: 35948233
Becske T, Kallmes DF, Saatci I, et al. Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial. Radiology. 2013;267:858–68.
doi: 10.1148/radiol.13120099 pubmed: 23418004
Lourenço GC, Dantas F, E Carvalho TS, et al. Endovascular treatment of intracranial aneurysms using the Derivo Embolization Device: a multicenter experience. J NeuroIntervent Surg. 2022; https://doi.org/10.1136/neurintsurg-2022-018648 .
doi: 10.1136/neurintsurg-2022-018648
Piñana C, Remollo S, Zamarro J, et al. Derivo embolization device for intracranial aneurysms: a Spanish multicenter retrospective study. J NeuroIntervent Surg. 2022; https://doi.org/10.1136/jnis-2022-019220 .
doi: 10.1136/jnis-2022-019220
Bond K, Brinjikji W, Murad M, et al. Diffusion-weighted imaging-detected ischemic lesions following endovascular treatment of cerebral aneurysms: a systematic review and meta-analysis. AJNR Am J Neuroradiol. 2017;38:304–9.
doi: 10.3174/ajnr.A4989 pubmed: 27856436 pmcid: 7963818
Hwang G, Kim JG, Song KS, et al. Delayed ischemic stroke after stent-assisted coil placement in cerebral aneurysm: characteristics and optimal duration of preventative dual antiplatelet therapy. Radiology. 2014;273:194–201.
doi: 10.1148/radiol.14140070 pubmed: 24918960

Auteurs

Lukas Goertz (L)

Faculty of Medicine and University Hospital, Department of Radiology and Neuroradiology, University of Cologne, Kerpener Straße 62, 50937, Cologne, Germany. lukas.goertz@uk-koeln.de.

David Zopfs (D)

Faculty of Medicine and University Hospital, Department of Radiology and Neuroradiology, University of Cologne, Kerpener Straße 62, 50937, Cologne, Germany.

Jonathan Kottlors (J)

Faculty of Medicine and University Hospital, Department of Radiology and Neuroradiology, University of Cologne, Kerpener Straße 62, 50937, Cologne, Germany.

Jan Borggrefe (J)

Department of Radiology, University Hospital Minden, Minden, Germany.

Lenhard Pennig (L)

Faculty of Medicine and University Hospital, Department of Radiology and Neuroradiology, University of Cologne, Kerpener Straße 62, 50937, Cologne, Germany.

Marc Schlamann (M)

Faculty of Medicine and University Hospital, Department of Radiology and Neuroradiology, University of Cologne, Kerpener Straße 62, 50937, Cologne, Germany.

Christoph Kabbasch (C)

Faculty of Medicine and University Hospital, Department of Radiology and Neuroradiology, University of Cologne, Kerpener Straße 62, 50937, Cologne, Germany.

Classifications MeSH